OTC外用薬の世界市場-2023年～2030年

市場概要

OTC外用薬の世界市場は2022年に468億米ドルに達し、2027年には790億米ドルに達するなど、有利な成長が予測されています。OTC外用薬の世界市場は、予測期間2023-2030年に6.9%のCAGRを示すと予測されています。

OTC（一般用医薬品）外用薬市場とは、さまざまな目的で皮膚に外用する非処方薬の市場を指します。これらの製品は処方箋なしで入手可能で、一般に、発疹、かゆみ、日焼け、にきび、虫刺されなどの軽度の皮膚疾患の治療に使用されます。通常、クリーム、ゲル、ローション、軟膏、スプレー、パッチなどの形で販売されています。

新薬の臨床試験の増加が、世界のOTC外用薬市場動向の需要を押し上げています。製剤技術の進歩と製品革新により、新しいOTC外用薬の製剤が開発されています。例えば、薬物送達メカニズムを改善し、有効性を高めた経皮パッチ、スプレー、ゲルが人気を博しています。

市場力学

消費者意識の高まりとセルフケアが世界のOTC外用薬市場の成長を牽引

ヘルスケアに対する消費者の意識の高まりとセルフケアへのシフトが大きな推進力となっています。OTC外用薬は、医療専門家の介入を必要とせず、一般的な健康状態や症状に対処することを可能にします。

また、フランスでは妊婦のセルフメディケーションの普及率が高いです。2021年1月に発表された「妊娠中の一般用鎮痛薬：世界の普及率と子孫の安全性に関する包括的レビュー」と題する調査によると、世界的に妊産婦の一般用鎮痛薬の消費は非常に多く、急激に増加しています。

eコマースとOTC外用薬のオンライン販売の拡大が世界のOTC外用薬市場の成長を後押し

eコマースの成長により、外用OTC薬の販売を含む小売の状況は一変しました。この動向はCOVID-19の大流行によってさらに加速し、オンラインショッピングがさらに脚光を浴びるようになっています。eコマース・プラットフォームは、実店舗に比べてより豊富な品揃えを提供しています。消費者は、地元の店舗では手に入らないような特殊な製品を含め、さまざまなブランドや処方のOTC外用薬を見つけることができます。この豊富な品揃えにより、消費者は自分のニーズに合った特定のOTC外用薬を見つけることができます。

OTC外用薬に伴う副作用が市場の成長を妨げる

不適切な用量の摂取は、副作用や薬物間相互作用の発生につながる可能性があります。具体的な副作用は、有効成分や個人の感受性やアレルギー反応によって異なります。特定の外用薬、特にニキビ治療や皮膚疾患に使用される外用薬は、治療部位の乾燥や過剰な湿気を引き起こすことがあります。これは、製剤や個人の反応にもよるが、皮が剥けたり、皮がむけたり、油分が増加したりする可能性があります。OTC薬の乱用による副作用には、不明瞭な会話、運動協調性の低下、認知能力の低下などがあります。

例えば、皮膚糸状菌症の治療で抗真菌外用薬を使用する場合、アレルギー反応、顔面そう痒症、吐き気、嘔吐など多くの副作用を引き起こす可能性があります。したがって、上記の要因のために、市場は予測期間中に低迷すると予想されます。

COVID-19影響分析

COVID-19の流行は世界のOTC外用薬市場に大きな影響を与えています。OTC外用薬を含む医薬品の世界のサプライチェーンは、封鎖、渡航制限、製造・流通の混乱により混乱しています。このため、特定のOTC外用薬の入手が困難となり、製品供給が変動しています。パンデミックにより、ヘルスケア・システム、規制機関、消費者の関心は、COVID-19に直接関連するワクチン、治療薬、医療機器などの必須ヘルスケア製品に移っています。このため、他の症状に対する一般用外用薬から注意と資源がそがれた可能性があります。

ロシア・ウクライナ紛争分析

ロシアとウクライナの紛争は、この地域での普及率が低く、主要な市場プレーヤーが不在であることから、世界のOTC外用薬市場に与える影響は中程度と推定されます。紛争の影響を受けた地域では、政府機関や規制当局が混乱しているため、OTC外用薬の規制プロセスや承認に課題があります。

このため、新製品のイントロダクションや既存製品の登録が妨げられ、市場力学に影響を与えています。しかし、原材料の輸出入による影響は、予測期間を通じて世界のOTC外用薬市場の成長にほとんど影響を与えないと予想されます。

目次

第1章 調査手法と範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響を与える要因
  • 促進要因
    • OTC医薬品の臨床試験数の増加
    • 規制当局の承認の増加と新しい製品の発売
  • 抑制要因
    • OTC外用薬に関連する副作用の機会
  • 機会
    • OTC外用薬における技術の進歩
  • 影響分析

第5章 業界分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• アンメットニーズ
• 規制分析

第6章 COVID-19の分析

第7章 ロシアとウクライナの戦争分析

第8章 製品タイプ別

• クリーム
• 軟膏
• ジェル
• ローション
• その他

第9章 アプリケーションの種類別

• 皮膚疾患
• 鎮痛剤
• スキンケア
• その他

第10章 流通チャネル別

• 病院薬局
• 小売薬局
• オンライン薬局

第11章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • イタリア
  • スペイン
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東とアフリカ

第12章 競合情勢

• 競合シナリオ
• 製品のベンチマーク
• 企業シェア分析
• 主な発展と戦略

第13章 企業プロファイル

• Galderma
• 会社概要
• 製品ポートフォリオと説明
• 財務概要
• 主な発展
• Sanofi
• Bayer AG
• Merck &Co., Inc.
• Bausch Health Company Inc.
• Johnson &Johnson（Janssen Biotech, Inc.）
• Pfizer
• Taisho Pharmaceuticals
• Takeda Pharmaceutical Co., Ltd.
• Teva Pharmaceutical Industries Ltd.

第14章 付録

Market Overview

The Global OTC Topical Drugs Market reached US$ 46.8 billion in 2022 and is projected to witness lucrative growth by reaching up to US$ 79.0 billion by 2027. The global OTC topical drugs market is expected to exhibit a CAGR of 6.9% during the forecast period 2023-2030.

The OTC (Over-the-Counter) topical drugs market refers to the market for non-prescription medications that are applied externally to the skin for various purposes. These products are available without a prescription and are commonly used for the treatment of minor skin conditions, such as rashes, itching, sunburn, acne, and insect bites. They are typically available in the form of creams, gels, lotions, ointments, sprays, and patches.

The increasing clinical trials for novel drugs are driving up demand for global OTC topical drug market trends. Advancements in formulation technologies and product innovation have resulted in the development of new topical OTC drug formulations. For example, transdermal patches, sprays, and gels with improved drug delivery mechanisms and enhanced efficacy have gained popularity.

Market Dynamics

Increasing Consumer Awareness and Self-Care Drives the Growth of the Global OTC Topical Drugs Market

Growing consumer awareness about healthcare and a shift towards self-care have been significant drivers. OTC topical drugs allow individuals to address common health conditions and symptoms without needing a healthcare professional's intervention.

Additionally, there is a high prevalence of self-medication among pregnant women in France. According to the research published in January 2021, titled "Over-the-counter analgesics during pregnancy: a comprehensive review of the global prevalence and offspring safety," there is a very high prevalence of maternal consumption of OTC analgesics globally, which is increasing sharply.

Expansion of E-commerce and Online Sales of Topical OTC Drugs is Boosting the Global OTC Topical Drugs Market Growth

The growth of e-commerce has transformed the retail landscape, including the sales of topical OTC drugs. This trend has accelerated further with the COVID-19 pandemic as online shopping gained even more prominence. E-commerce platforms offer a more extensive product selection compared to physical stores. Consumers can find a variety of OTC topical drugs from different brands and formulations, including specialized products that may not be available in their local stores. This expanded product range allows consumers to find the specific OTC topical drug that suits their needs.

Side Effects Associated with OTC Topical Drugs will Hamper the Growth of the Market

The ingestion of inappropriate doses can lead to side effects and the occurrence of adverse reactions and drug-drug interactions. The specific side effects can vary depending on the active ingredient and the individual's sensitivity or allergic reactions. Certain topical drugs, especially those used for acne treatment or skin conditions, may cause dryness or excessive moisture in the treated area. This can lead to flaking, peeling, or increased oiliness, depending on the formulation and individual response. The side effects of OTC drug abuse which include slurred speech, impaired motor coordination, impaired cognitive abilities.

For instance, during the treatment of dermatophytosis by using anti-fungal topical drugs it can lead to many side effects which include allergic reactions, intensive facial pruritus, nausea and vomiting. Hence, owing to the above factors, the market is expected to hamper over the forecast period.

COVID-19 Impact Analysis

The COVID-19 pandemic has had a significant impact on the global OTC topical drug market. The global supply chains for pharmaceutical products, including OTC topical drugs, have been disrupted due to lockdowns, travel restrictions, and disruptions in manufacturing and distribution. This has led to challenges in the availability of certain OTC topical drugs and fluctuations in product supply. The pandemic has shifted the focus of healthcare systems, regulatory bodies, and consumers toward essential healthcare products, including vaccines, therapeutics, and medical devices directly related to COVID-19. This may have diverted attention and resources away from OTC topical drugs for other conditions.

Russia-Ukraine Conflict Analysis

The Russia-Ukraine conflict is estimated to have a moderate impact on the global topical OTC drugs market, owing to the low prevalence and absence of key market players in this region. Regulatory processes and approvals for OTC topical drugs face challenges in conflict-affected regions due to the disruption of government institutions and regulatory authorities.

This hinder the introduction of new products or the registration of existing ones, impacting the market dynamics. However, the impact of the import and export of raw materials is expected to have little influence over the global OTC topical drug market growth over the forecast period.

Segment Analysis

The global OTC topical drug market is segmented based on product type, application type, distribution channel, and region.

OTC Topical Creams in the Product Type Segment Account for 37.3% of the Market Share Owing to Rising Novel Product Launches

OTC topical creams are non-prescription medications that are applied directly to the skin for various purposes. They are available over-the-counter without the need for a prescription and are commonly used for the treatment of minor skin conditions, including rashes, itching, sunburn, insect bites, and mild pain relief.

For instance, on May 15, 2023, the USA-based Calgenex Corp introduced Dermalleve, its new over-the-counter topical drug treatment for psoriasis, eczema, and seborrheic dermatitis. The product combines maximum-strength anti-pruritic medicine with natural skin conditioners and emollients to stop the itching, reduce inflammation and support the body's healing process. Dermalleve contains 1% hydrocortisone, the maximum strength OTC anti-pruritic allowed by the US FDA.

On April 19, 2023, Resilia Pharmaceuticals announced the relaunch of Solace Cream to treat the signs and symptoms of eczema. The product, which is now available over-the-counter (OTC), had previously received approval from the Food and Drug Administration under the brand name PruMyx for prescription use. Thus, owing to the above factors, the product type segment is expected to hold the largest market share over the forecast period

Geographical Analysis

North America Accounted for Approximately 39.4% of the Market Share in 2022, Owing to the Increasing Research and Development Activities and Well-Established Healthcare Infrastructure

North America, particularly the United States and Canada, has a well-developed healthcare infrastructure, including a robust pharmaceutical industry, advanced research facilities, and a strong regulatory framework. This enables efficient product development, clinical trials, and regulatory approvals for OTC topical drugs.

Skin conditions are prevalent in North America, with a significant portion of the population experiencing issues such as acne, eczema, dermatitis, and psoriasis. The increasing prevalence of these conditions drives the demand for OTC topical drugs as consumers seek convenient and cost-effective solutions.

North America has a strong retail infrastructure, with well-established pharmacy chains, drugstores, supermarkets, and convenience stores. These retail channels provide wide distribution networks for OTC topical drugs, making them easily accessible to consumers. Additionally, the growth of e-commerce platforms has further expanded the availability and convenience of purchasing OTC topical drugs online. Thus, from the above factors, the North American region is expected to hold the largest market share over the forecast period.

Competitive Landscape

The major global players in the market include: Merck & Co., Inc., Johnson & Johnson, Bayer AG, Galderma, Sanofi, Taisho Pharmaceuticals, Takeda Pharmaceuticals, Novartis AG, Pfizer, and Teva Pharmaceuticals.

Why Purchase the Report?

• To visualize the global OTC topical drug market segmentation based on the product type, application type, distribution channel, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of OTC topical market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The Global OTC Topical Market Report Would Provide Approximately 95 tables, 95 figures, and 180 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Application Type
• 3.3. Snippet by Distribution Channels
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing Number of Clinical Trials of OTC Drugs
    • 4.1.1.2. Rising Regulatory Approvals and Novel Product Launches
  • 4.1.2. Restraints
    • 4.1.2.1. Side Effects Associated with OTC Topical Drugs Opportunity
  • 4.1.3. Opportunity
    • 4.1.3.1. Technological Advancements in OTC Topical Drug Formulations
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's 5 Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Unmet Needs
• 5.4. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID-19
  • 6.1.2. Scenario During COVID-19
  • 6.1.3. Scenario Post COVID-19
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturers' Strategic Initiatives
• 6.6. Conclusion

7. Russia-Ukraine War Analysis

8. By Product Type

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 8.1.2. Market Attractiveness Index, By Product Type
• 8.2. Creams
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Ointments
• 8.4. Gels
• 8.5. Lotions
• 8.6. Others

9. By Application type

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application Type
  • 9.1.2. Market Attractiveness Index, By Application Type
• 9.2. Skin Diseases
• 9.3. Pain Relief
• 9.4. Skincare
• 9.5. Others

10. By Distribution Channel

• 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
• 10.1.2. Market Attractiveness Index, By Distribution Channel
• 10.2. Hospital Pharmacies
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 10.3. Retail Pharmacies
• 10.4. Online Pharmacies

11. By Region

• 11.1. Introduction
  • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 11.1.2. Market Attractiveness Index, By Region
• 11.2. North America
  • 11.2.1. Introduction
  • 11.2.2. Key Region-Specific Dynamics
  • 11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
  • 11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 11.2.6.1. The U.S.
    • 11.2.6.2. Canada
    • 11.2.6.3. Mexico
• 11.3. Europe
  • 11.3.1. Introduction
  • 11.3.2. Key Region-Specific Dynamics
  • 11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
  • 11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 11.3.6.1. Germany
    • 11.3.6.2. The U.K.
    • 11.3.6.3. France
    • 11.3.6.4. Italy
    • 11.3.6.5. Spain
    • 11.3.6.6. Rest of Europe
• 11.4. South America
  • 11.4.1. Introduction
  • 11.4.2. Key Region-Specific Dynamics
  • 11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
  • 11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 11.4.6.1. Brazil
    • 11.4.6.2. Argentina
    • 11.4.6.3. Rest of South America
• 11.5. Asia Pacific
  • 11.5.1. Introduction
  • 11.5.2. Key Region-Specific Dynamics
  • 11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
  • 11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
  • 11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 11.5.6.1. China
    • 11.5.6.2. India
    • 11.5.6.3. Japan
    • 11.5.6.4. Australia
    • 11.5.6.5. Rest of Asia Pacific
• 11.6. Middle East and Africa
  • 11.6.1. Introduction
  • 11.6.2. Key Region-Specific Dynamics
  • 11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Type
  • 11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Type
  • 11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channels

12. Competitive Landscape

• 12.1. Competitive Scenario
• 12.2. Product Benchmarking
• 12.3. Company Share Analysis
• 12.4. Key Developments and Strategies

13. Company Profiles

• 13.1. Galderma
  • 13.1.1. Company Overview
  • 13.1.2. Product Portfolio and Description
  • 13.1.3. Financial Overview
  • 13.1.4. Key Developments
• 13.2. Sanofi
• 13.3. Bayer AG
• 13.4. Merck & Co., Inc.
• 13.5. Bausch Health Company Inc.
• 13.6. Johnson & Johnson (Janssen Biotech, Inc.)
• 13.7. Pfizer
• 13.8. Taisho Pharmaceuticals
• 13.9. Takeda Pharmaceutical Co., Ltd.
• 13.10. Teva Pharmaceutical Industries Ltd.

LIST NOT EXHAUSTIVE

14. Appendix

• 14.1. About Us and Services
• 14.2. Contact Us